Background: Chloroquine inhibits platelet aggregation. Because platelet aggregation may lead to the lysis of platelets, the effect of chloroquine administration on circulating platelet survival was studied.
Methods and Results: Platelets harvested from the blood of male inbred (WAG) rats were labeled with 111Indium oxine and returned to other inbred rats. At timed intervals, blood samples were drawn from the rats and taken for radioactivity estimation. In some experi ments, the rats (n = 10) received chloroquine (10 mg/kg) intraperitoneally daily for 3 days. Control rats (n = 10) received normal saline. Indium-labeled platelets disappeared expo nentially in control and test rats. The fraction of indium disappearing/h was significantly less in chloroquine-treated rats than in control rats (0.0368 ± 0.0016 vs 0.0520 ± 0.0016, mean ± SEM; P < .001). In all, 99% of the labeled platelets disappeared in 5.3 days in chloro quine-treated rats and 3.7 days in control rats.
Conclusions: Chloroquine administration increases the life span of circulating platelets in rats. If the results are confirmed in humans, chloroquine may prevent the shortened platelet survival and thrombocytopenia common in malarial infection and other thrombotic disorders.
Sofola AO, Olube ID, Adegoke F.The effects of chronic chloroquine toxicity on blood pressure in rats . J Trop Med Hyg84:249, 1981
2.
Augustijns P. , Geusens P., Verbeke N.Chloroquine levels in blood during chronic treatment of patients with rheumatoid arthritis. Eur J Clin Pharmacol42:429, 1992
Kinlough-Rathbone RC, Mustard JF, Perry PW, et al. Factors influencing the disaggregation of human and rabbit platelets. Thromb Hemost49:162, 1983
5.
Bertrand E., Cloitre B., Ticolat R., et al. Antiaggregatory action of chloroquine. Med Trop (Mars) 50:143,1990
6.
Jancinova V. , Nosal R., Petrikova M.On the inhibitory effect of chloroquine on blood platelet aggregation. Thromb Res74:295, 1994
7.
Nosal R., Jancinova V, Petrikovam.Chloroquine inhibits platelets at the arachidonic acid pathway. Thromb Res77:531,1995
8.
Osim EE, Mudzudzu B., Musabayane CT, et al. In vivo effect of chloroquine on platelet aggregation in anaesthetized rats. Haematologica84:92, 1999
9.
Osim EE, Adegunloye BJ, Emeribe AOIn vivo platelet aggregation in acute malaria. Acta Trop49:227, 1991
10.
Holmsen H.The platelet: Its membrane, physiology and biochemistry. Clin Hematol1:235,1972
11.
Essien EM, Ebhota MIPlatelet hypersensitivity in acute malaria (Plasmodium falciparum) infection in man. Thromb Hemost (Stuttgart ) 46:547, 1981
12.
Inyang AL, Okpako D., Essien EMDecrease in platelet survival and total platelet sialic acid concentration in rats infected with Plasmodium berghei. Afr J Med Med Sci24:41, 1995
13.
Heal JM, Mullin A., Blumberg N.The importance of ABH antigens in platelet cross matching. Transfusion29: 514,1982
14.
Osim EE, Wyllie JHLoss of 5-hydroxyptamine from mammalian circulating labelled platelets . J Physiol340: 77,1983
15.
Scheffel U. , McIntyre PA, Evatt B., et al. Evaluation of 111Indium as a new high photon yield gamma-emitting physiological platelet label. Johns Hopkins Med J140: 285,1977
16.
Hawker RJ, Hawker LM, Wilkinson ARUse of 111Indium oxine to label human platelet platelets. Lancet ii:483,1978
17.
Odell TT Jr, Gamble FN, Furth J.Life span of naturally labelled rat platelets . Fed Proc12:298,1953
18.
Odell TT Jr, Tausche FG, Furth J.Life span of in vivo labelled transfused platelets . Fed Proc13:440,1954
19.
Aster RHStudies on the fate of platelets in rats and man. Blood34:117, 1969
20.
Abdel-Gayoum AA, Haider SS, Tash FM, et al. Effect of chloroquine on some carbohydrate metabolic pathways: Contents of GHS, ascorbic and lipid peroxidation in rats . Pharmacol Toxicol71:161,1992
21.
Okanlanson AO, Noronha CC, Ashiru OAAn investigation into the effects of chloroquine on fertility of male rats. West Afr J Med12:118,1993
22.
Harker LA, Slichter SJStudies on platelet and fibrinogen kinetics in patients with prosthetic heart valves. N Engl J Med283:1302,1970
23.
Genton E., Gent M., Hirsh J., et al. Platelet inhibiting drugs in the prevention of clinical thrombotic disease. N Engl J Med293:1174,1975
24.
Steel PP, Carroll J., Overfield D., et al. Effect of sulphinpyrazone on platelet survival time in patients with transient ischemic attacks. Stroke8:396, 1977
25.
De Chavanne M, Lagarde M.Effects of chloroquine on adenylate cyclase and phosphodiesterase activities of human platelets. Experientia30:34, 1973
26.
Cazenave JP, Hommendigek S.Acquired Thrombopathies in Blood Platelets (French) Samama M. Blackwell, Paris, Doin Editors, pp 138-139,1983
27.
Slichter SJ , Weiden PL, O'Donnell MR, et al. Interruption of tumor-associated platelet consumption with platelet enzyme inhibitors. Blood59:1252, 1982
28.
Holme S., Bode A., Heaton WA, et al. Improved maintenance of platelet in vivo viability during storage when using a synthetic medium with inhibitors. J Lab Clin Med119:144,1992
29.
Cummins D., Faint R., Yardumian D., et al. The in vitro and ex vivo effects of chloroquine sulphate on platelet function. Implications for malaria prophylaxis in patients with impaired hemostasis. J Trop Med Hyg93:112,1990
